LianBio ADR Analysis
LianBio ADR is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of LianBio ADR delisted stock analysis is to determine its intrinsic value, which is an estimate of what LianBio ADR is worth, separate from its market price. There are two main types of LianBio ADR's stock analysis: fundamental analysis and technical analysis.
The LianBio ADR stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. LianBio ADR is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. LianBio Stock trading window is adjusted to America/New York timezone.
LianBio |
LianBio Stock Analysis Notes
About 79.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. LianBio ADR recorded a loss per share of 0.82. The entity last dividend was issued on the 15th of March 2024. LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. To find out more about LianBio ADR contact Yizhe Wang at 609 486 2308 or learn more at https://www.lianbio.com.LianBio ADR Investment Alerts
| LianBio ADR is not yet fully synchronised with the market data | |
| LianBio ADR has some characteristics of a very speculative penny stock | |
| LianBio ADR has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (87.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LianBio ADR currently holds about 329.3 M in cash with (83.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04. | |
| Over 79.0% of the company shares are owned by institutional investors |
LianBio ADR Upcoming and Recent Events
Earnings reports are used by LianBio ADR to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
LianBio Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.47 M.LianBio ADR Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LianBio ADR insiders, such as employees or executives, is commonly permitted as long as it does not rely on LianBio ADR's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LianBio ADR insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ehong Gu over six months ago Disposition of 17889 shares by Ehong Gu of LianBio ADR at 0.32 subject to Rule 16b-3 | ||
Yu Debra over a year ago Acquisition by Yu Debra of 1000000 shares of LianBio ADR at 1.71 subject to Rule 16b-3 | ||
Adam Stone over a year ago Exercise or conversion by Adam Stone of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Perceptive Advisors Llc over a year ago Exercise or conversion by Perceptive Advisors Llc of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Chen Wei Wei over a year ago Acquisition by Chen Wei Wei of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Perceptive Advisors Llc over a year ago LianBio ADR exotic insider transaction detected | ||
Perceptive Advisors Llc over a year ago Acquisition by Perceptive Advisors Llc of 36000 shares of LianBio ADR subject to Rule 16b-3 | ||
Brianne Jahn over a year ago Acquisition by Brianne Jahn of 224005 shares of LianBio ADR subject to Rule 16b-3 |
LianBio ADR Outstanding Bonds
LianBio ADR issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LianBio ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LianBio bonds can be classified according to their maturity, which is the date when LianBio ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding LianBio ADR to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |